The mechanisms of action of antitumor compounds.
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001388:Aziridines / Q000494:pharmacology; D002453:Cell Cycle / Q000187:drug effects; D005492:Folic Acid / Q000031:analogs & derivatives; D005493:Folic Acid Antagonists / Q000494:pharmacology; D006801:Humans; D008558:Melphalan / Q000494:pharmacology; D008928:Mitochondria / Q000187:drug effects; D009588:Nitrogen Mustard Compounds / Q000494:pharmacology; D009607:Nitrosourea Compounds / Q000494:pharmacology; D009841:Oligonucleotides / Q000494:pharmacology; D011741:Pyrimidine Nucleosides / Q000494:pharmacology; D013852:Thiotepa / Q000494:pharmacology; D013721:Triethylenephosphoramide / Q000494:pharmacology
D000477:Alkylating Agents; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D001388:Aziridines; D005493:Folic Acid Antagonists; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D009841:Oligonucleotides; D011741:Pyrimidine Nucleosides; D013852:Thiotepa; D005492:Folic Acid; D013721:Triethylenephosphoramide; D008558:Melphalan